Pay in 4 interest-free payments of $32.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
CD44v6 is a promising target for cancer diagnosis and therapy
Bryckaert M
Genetic and epidemiologic studies have confirmed human physiology and disease states mediated by this receptor in immunity
The unopened kit is stored at 2-8 ℃ and has a validity period of one year
A number of lines of evidence suggest that a CD30L/CD30-mediated signal is involved in the development of diseases associated with both Th1 and Th2 cell responses
Tissue Factor Fc Chimera Protein, Human OneStep ELISA Kit CD44v6 is a promising targetProduct Specification Species Human Accession P13726 Amino Acid Sequence Ser33 Glu251, with C terminal human IgG Fc
US$ 10.00
US$ 10.00
US$ 10.00
US$ 20.17
US$ 10.00
US$ 20.39
US$ 69.99
US$ 10.00
US$ 49.99
US$ 10.00
US$ 10.00
US$ 10.00
US$ 10.99